Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circulase in Critical Leg Ischemia with Peripheral Revascularization
NCT00059657Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Aug 2001
- Countries
- 2
01
Overview
A Phase 3 trial of ecraprost in critical limb ischemia (CLI), sponsored by Mitsubishi Tanabe Pharma Corporation. Started Aug 2001; status: completed.
02
Drugs
ecraprost
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT00059657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00059657.